MANFRINATO, Maria Cristina
 Distribuzione geografica
Continente #
NA - Nord America 6.461
AS - Asia 3.659
EU - Europa 2.104
SA - Sud America 563
Continente sconosciuto - Info sul continente non disponibili 143
AF - Africa 90
OC - Oceania 7
Totale 13.027
Nazione #
US - Stati Uniti d'America 6.290
SG - Singapore 1.325
CN - Cina 980
BR - Brasile 422
VN - Vietnam 408
IT - Italia 407
UA - Ucraina 316
DE - Germania 315
HK - Hong Kong 274
GB - Regno Unito 233
TR - Turchia 166
FI - Finlandia 165
PL - Polonia 122
FR - Francia 116
BD - Bangladesh 113
JP - Giappone 97
RU - Federazione Russa 97
SE - Svezia 91
CA - Canada 86
IN - India 70
MX - Messico 54
ID - Indonesia 46
AR - Argentina 44
NL - Olanda 41
EE - Estonia 37
IQ - Iraq 29
ZA - Sudafrica 28
BE - Belgio 26
CO - Colombia 26
EC - Ecuador 25
CZ - Repubblica Ceca 22
ES - Italia 22
MA - Marocco 18
MY - Malesia 17
LT - Lituania 14
PK - Pakistan 14
PY - Paraguay 13
SA - Arabia Saudita 13
UZ - Uzbekistan 12
VE - Venezuela 12
AE - Emirati Arabi Uniti 11
IE - Irlanda 11
IR - Iran 11
JM - Giamaica 11
PH - Filippine 10
AT - Austria 8
CL - Cile 8
ET - Etiopia 8
KE - Kenya 8
RO - Romania 8
EG - Egitto 7
KR - Corea 7
NP - Nepal 7
TN - Tunisia 7
TW - Taiwan 7
UY - Uruguay 7
AL - Albania 6
BG - Bulgaria 6
PT - Portogallo 6
SD - Sudan 6
KZ - Kazakistan 5
PS - Palestinian Territory 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AU - Australia 4
BO - Bolivia 4
EU - Europa 4
HN - Honduras 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
OM - Oman 4
BH - Bahrain 3
CH - Svizzera 3
HU - Ungheria 3
IL - Israele 3
JO - Giordania 3
KW - Kuwait 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
GE - Georgia 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
NI - Nicaragua 2
PE - Perù 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AW - Aruba 1
BW - Botswana 1
CD - Congo 1
Totale 12.877
Città #
Singapore 854
Ashburn 673
San Jose 527
Woodbridge 521
Fairfield 340
Beijing 333
Jacksonville 331
Chandler 324
Houston 314
Santa Clara 309
Ann Arbor 281
Hong Kong 266
Council Bluffs 186
Dallas 140
Wilmington 139
Ferrara 133
Ho Chi Minh City 133
Cambridge 113
Seattle 113
Nanjing 110
Warsaw 107
Los Angeles 103
Izmir 100
Tokyo 95
Munich 87
Princeton 81
Hanoi 80
New York 77
Boardman 69
Lauterbourg 62
Helsinki 61
Milan 59
Dearborn 57
São Paulo 41
Shanghai 38
Nanchang 37
Shenyang 35
Buffalo 34
San Diego 33
Turku 33
Phoenix 32
London 31
Mexico City 31
Tianjin 30
Changsha 29
Montreal 27
Orem 27
Bologna 26
Brussels 26
Toronto 26
Chennai 23
Jakarta 22
Poplar 21
Da Nang 20
The Dalles 20
Bremen 19
Brooklyn 19
Chicago 19
Denver 19
Frankfurt am Main 19
Brno 18
Hefei 18
Jiaxing 17
Boston 16
Hebei 16
Haiphong 15
Moscow 15
Ningbo 15
Orange 15
Stockholm 15
Addison 14
Atlanta 14
San Francisco 14
Jinan 13
Norwalk 13
Rome 13
Manchester 12
Philadelphia 12
San Mateo 12
Amsterdam 11
Augusta 11
Dublin 11
Redwood City 11
Washington 11
Hillsboro 10
Mountain View 10
Quito 10
Tashkent 10
Auburn Hills 9
Baghdad 9
Brasília 9
Charlotte 9
Curitiba 9
Dong Ket 9
Guangzhou 9
Johannesburg 9
Kraków 9
Ninh Bình 9
Kuala Lumpur 8
Paris 8
Totale 8.393
Nome #
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 281
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 255
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 252
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 246
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 246
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 228
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 219
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 218
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 209
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 206
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 200
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 200
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 199
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 197
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 197
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 195
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 194
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 193
Mutual communication of envelope glycoproteins of paramixoviruses 191
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 191
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 189
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 189
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 186
Substrate binding to 6-phosphogluconate dehydrogenase 183
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 180
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 179
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 178
Biochemical study in adult population with stroke in Ferrara, Fabry disease 176
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 172
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 171
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 169
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 169
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 167
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 165
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 158
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 157
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 157
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 156
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 154
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 152
Domain structure of the hemagglutinin-neuraminidase from sendai virus 147
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 146
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 146
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 145
Purification of transglutaminase enzyme from L. infantum promastigotes 145
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 142
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 140
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 137
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 136
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 133
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 132
MMP-9 isoforms in serum of Multiple Sclerosis patients 131
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 130
null 128
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 127
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 127
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 127
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 126
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 126
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 125
Effects of anticoagulants on the activity of gelatinases 122
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 115
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 112
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 112
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 111
null 110
Effects of anticoagulants on the activity of gelatinases 110
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 108
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 107
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 105
null 104
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 104
The influence of different replacement solutions on neutrophils response 98
null 97
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 97
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 96
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 94
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 93
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 92
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 90
null 88
Commentary on the Issue of Leishmania Infection: Focus on Some Pathogenetic, Clinical, and Epidemiological Aspects 82
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 78
BACE-1 and ADAM-10 as Potential Peripheral Biomarkers for Alzheimer’s Disease 61
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 60
null 53
null 49
Sex differences in biomarkers: Implications for age-related diseases 37
Sex and Gender in Ageing and Longevity: Highlights from an International Course 22
Totale 13.027
Categoria #
all - tutte 57.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 161
Totale 58.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022618 0 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/20251.818 49 42 153 73 216 152 68 98 263 232 276 196
2025/20265.126 502 227 410 610 685 322 655 285 474 547 263 146
2026/2027396 149 247 0 0 0 0 0 0 0 0 0 0
Totale 13.027